Biodel Inc (BIOD)

0.41
0.02 4.60
NASDAQ : Health Care
Prev Close 0.43
Open 0.42
Day Low/High 0.41 / 0.45
52 Wk Low/High 0.22 / 1.07
Volume 467.17K
Avg Volume 473.60K
Exchange NASDAQ
Shares Outstanding 64.15M
Market Cap 28.23M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

4 Stocks Under $10 Making Big Moves Higher

4 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

3 Breakout Biotech Stocks Trading for Under $10

3 Breakout Biotech Stocks Trading for Under $10

Keep these biotech stocks trading for under $10 on your breakout trading radar.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AAN, AXTI Downgrades: ASB, CVRR, EJ, IKNX, NVFY Initiations: BIOD Read on to get TheStreet Quant Ratings' detailed report:

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Biodel Reports Second Quarter Fiscal Year 2014 Financial Results

Biodel Reports Second Quarter Fiscal Year 2014 Financial Results

Conference Call and Audio Webcast Will be Held Today, May 13th, at 5:00 p.m. ET

5 Biotech Stocks to Trade for Breakouts

5 Biotech Stocks to Trade for Breakouts

Here's a technical look at five potentially explosive biotech stock plays.

Biodel Reports First Quarter Fiscal Year 2014 Financial Results

Biodel Reports First Quarter Fiscal Year 2014 Financial Results

Conference Call and Audio Webcast Will be Held Today, February 6th, at 5:00 p.m. ET

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

First Week of BIOD February 22nd Options Trading

First Week of BIOD February 22nd Options Trading

Investors in Biodel Inc saw new options begin trading this week, for the February 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIOD options chain for the new February 22nd contracts and identified one put and one call contract of particular interest.

Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets

Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets

As the diabetes insulin market continues to heat up, Biodel offers significant upside with its new offerings.

Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results

Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results

Conference Call and Audio Webcast Will be Held Today, December 18th, at 5:00 p.m. ET

Biodel Advances Ultra-Rapid-Acting Concentrated Insulin Formulation Into Clinical Development

Biodel Advances Ultra-Rapid-Acting Concentrated Insulin Formulation Into Clinical Development

Top Line Data Expected in First Quarter of 2014

Interesting BIOD Put And Call For November 16th

Interesting BIOD Put And Call For November 16th

Investors in Biodel Inc saw new options become available this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIOD options chain for the new November 16th contracts and identified one put and one call contract of particular interest.

January 2014 Options Now Available For Biodel (BIOD)

January 2014 Options Now Available For Biodel (BIOD)

Investors in Biodel Inc saw new options become available today, for the January 2014 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 124 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Biodel Fails to Excite Investors With Me-Too Mealtime Insulin

Biodel Fails to Excite Investors With Me-Too Mealtime Insulin

But if Biodel shares are still too cheap, MannKind is too expensive.

Biodel's BIOD-123 Achieves Primary Endpoint In Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable To Humalog(R)

Biodel's BIOD-123 Achieves Primary Endpoint In Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable To Humalog(R)

Conference Call and Webcast Will be Held Monday, September 9th, at 8:00 a.m. EDT

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks look poised to break out and trade higher from current levels.

Biotech's Next Big Thing: Fall Trials

Biotech's Next Big Thing: Fall Trials

Its been a busy summer for biotech, but the coming weeks will heat up with trials from Biodel, Achillon and Coronado, says Adam Feuerstein, Sr. Columnist at TheStreet.

First Week Of October 19th Options Trading For Biodel (BIOD)

First Week Of October 19th Options Trading For Biodel (BIOD)

Investors in Biodel Inc saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIOD options chain for the new October 19th contracts and identified one put and one call contract of particular interest.